港股電影概念股集體下跌 2022年春節檔電影票房低於映前市場預期
格隆匯2月7日丨貓眼娛樂跌超5%,阿里影業跌近5%,稻草熊娛樂和IMAX中國跌超1%,歡喜傳媒跌0.7%。2022年春節檔已正式收官。據燈塔專業版數據顯示,截至2月7日0時,2022春節檔(1.31-2.6)總票房報收60.25億元。機構稱,2022年春節檔電影票房表現雖然較疫情前2019年春節檔有小幅提升,但較2021年有明顯下滑,且低於映前市場預期。還值得注意的是,2022年春節檔的平均票價首次突破50元大關,高票價之下,觀影人次顯著下降。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.